Literature DB >> 3050941

Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension.

D Patakas1, D Georgopoulos, H Rodini, P Christaki.   

Abstract

Ten patients with chronic obstructive pulmonary disease (COPD) with normal left ventricular function were given a single dose of captopril (0.25 mg/kg). Mean systemic arterial pressure, heart rate and coronary flow to the right ventricle were reduced significantly after captopril. In contrast captopril did not cause a significant fall in pulmonary arterial pressure or pulmonary vascular resistance. We conclude that captopril fails to produce haemodynamic benefits in such hypoxic patients and that angiotensin II is not playing a significant role in maintaining pulmonary vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050941      PMCID: PMC2428827          DOI: 10.1136/pgmj.64.749.193

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.

Authors:  R M Zakheim; L Mattioli; A Molteni; K B Mullis; J Bartley
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

2.  Inhibition of converting enzyme activity by acute hypoxia in dogs.

Authors:  S A Stalcup; J S Lipset; P M Legant; P J Leuenberger; R B Mellins
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-02

Review 3.  Angiotensin-converting enzyme inhibitors: past, present, and bright future.

Authors:  C R Edwards; P L Padfield
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

4.  Abnormalities of sodium and H2O handling in chronic obstructive lung disease.

Authors:  M O Farber; L R Roberts; M H Weinberger; G L Robertson; N S Fineberg; F Manfredi
Journal:  Arch Intern Med       Date:  1982-07

5.  Effects of captopril on pulmonary haemodynamics.

Authors:  C Richard; J L Ricome; A Rimailho; M Conrad; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Feline hypoxic pulmonary vasoconstriction is not blocked by the angiotensin I-converting enzyme inhibitor, captopril.

Authors:  R L Prewitt; C W Leffler
Journal:  J Cardiovasc Pharmacol       Date:  1981 Mar-Apr       Impact factor: 3.105

7.  Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.

Authors:  T B Levine; J N Cohn
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

8.  Renin-aldosterone and angiotensin-converting enzyme during prolonged altitude exposure.

Authors:  J S Milledge; D M Catley; M P Ward; E S Williams; C R Clarke
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-09

9.  Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.

Authors:  D N Sharpe; J E Douglas; R J Coxon; B Long
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

Review 10.  Acute right heart failure.

Authors:  H P Wiedemann; R A Matthay
Journal:  Crit Care Clin       Date:  1985-11       Impact factor: 3.598

View more
  5 in total

1.  Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.

Authors:  R I Cargill; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

2.  Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flow.

Authors:  B J Lipworth; K D Dagg
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

Review 3.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

Review 4.  Pulmonary hypertension associated with COPD.

Authors:  Jean Elwing; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

5.  Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease.

Authors:  Nicholas W Morrell; Matthew A Higham; Peter G Phillips; B Haleema Shakur; Paul J Robinson; Ray J Beddoes
Journal:  Respir Res       Date:  2005-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.